Patents by Inventor Tulio Suarez

Tulio Suarez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted tricyclics
    Patent number: 6713645
    Abstract: A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: March 30, 2004
    Assignee: Eli Lilly and Company
    Inventors: Nicholas James Bach, Susan Elizabeth Draheim, Robert Delane Dillard, Edward David Mihelich, Jason Scott Sawyer, Douglas Wade Beight, Michael LeRoy Phillips, Tulio Suarez, Daniel Jon Sall, Jolie Anne Bastian, Michael Lyle Denney, Gary Alan Hite, Michael Dean Kinnick, Robert Theodore Vasileff, John Michael Morin, Jr., Ho-Shen Lin, Michael Enrico Richett, Richard Waltz Harper, John McNeill McGill, III, Benjamin Alan Anderson, Nancy Kay Harn, Richard James Loncharich, Richard Walter Schevitz
  • Indole sPLA2 inhibitors
    Patent number: 6451839
    Abstract: A class of novel indole is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of inflammatory diseases such as septic shock.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: September 17, 2002
    Assignee: Eli Lilly and Company
    Inventors: Nicholas James Bach, Robert Delane Dillard, Susan Elizabeth Draheim, Edward David Mihelich, Tulio Suarez
  • Substituted tricyclics
    Patent number: 6177440
    Abstract: A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: January 23, 2001
    Assignee: Eli Lilly and Company
    Inventors: Nicholas James Bach, Susan Elizabeth Draheim, Robert Delane Dillard, Edward David Mihelich, Jason Scott Sawyer, Douglas Wade Beight, Michael LeRoy Phillips, Tulio Suarez, Daniel Jon Sall, Jolie Anne Bastian, Michael Lyle Denney, Gary Alan Hite, Michael Dean Kinnick, Robert Theodore Vasileff, John Michael Morin, Jr., Ho-Shen Lin, Michael Enrico Richett, Richard Waltz Harper, John McNeill McGill, III, Benjamin Alan Anderson, Nancy Kay Harn, Richard James Loncharich, Richard Walter Schevitz
  • Pyrazoles as human non-pancreatic secretory phospholipase A.sub.2 inhibitors
    Patent number: 5972972
    Abstract: A class of novel pyrazoles is disclosed together with the use of such compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
    Type: Grant
    Filed: December 3, 1997
    Date of Patent: October 26, 1999
    Assignee: Eli Lilly and Company
    Inventors: Edward D. Mihelich, Tulio Suarez, Gary A. Hite, Peter J. Doman, Stuart E. Willetts
  • N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors
    Patent number: 5283361
    Abstract: This invention relates to N-hydroxy-N-[3-[2-(4'-halophenylthio)phenyl]prop-2-enyl]ureas, formulations containing those compounds and methods of using such compounds as 5-lipoxygenase inhibiting agents.
    Type: Grant
    Filed: April 8, 1992
    Date of Patent: February 1, 1994
    Assignee: Eli Lilly and Company
    Inventors: Gary A. Hite, Edward D. Mihelich, David W. Snyder, Tulio Suarez
  • N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents
    Patent number: 5130485
    Abstract: This invention relates to N-hydroxy-N-[3-(2-substituted phenyl)prop-2-enyl]ureas and thioureas, formulations containing those compounds, and methods of using such compounds as 5-lipoxygenase inhibiting agents.
    Type: Grant
    Filed: April 23, 1991
    Date of Patent: July 14, 1992
    Assignee: Eli Lilly and Company
    Inventors: Gary A. Hite, Edward D. Mihelich, David W. Snyder, Tulio Suarez
  • 5-Lipoxygenase inhibitors
    Patent number: 5028629
    Abstract: This invention relates to 2-(substituted)-N-hydroxy-N-alkylcinnamamides of the formula: ##STR1## where R.sup.1 is C.sub.1 -C.sub.4 alkyl;n is 0 or 1;R.sup.2 is trifuloromethyl, C.sub.1 -C.sub.10 alkyl, phen(C.sub.1 -C.sub.4)alkylene or ##STR2## where m is 0, 1 or 2 and R.sup.3 is C.sub.1 -C.sub.4 alkyl; X is C.sub.1 -C.sub.6 alkyl, phenyl, phen(C.sub.1 -C.sub.4)alkylene where the phenyl ring is unsubstituted or monosubstituted with --S(O).sub.m --R.sup.3 and m and R.sup.3 are as defined above, or ##STR3## where m is 0, 1 or 2 and R.sup.4 is C.sub.2 -C.sub.12 alkenyl, C.sub.2 -C.sub.12 alkynyl, or unsubstituted or monosubstituted C.sub.1 -C.sub.20 alkyl where the substituent is CF.sub.3, C.sub.3 -C.sub.8 cycloalkyl, or phenyl,or a pharmaceutically acceptable salt thereof; formulations containing those compounds and methods of using such compounds as 5-lipoxygenase inhibiting agents.
    Type: Grant
    Filed: March 28, 1990
    Date of Patent: July 2, 1991
    Assignee: Eli Lilly and Company
    Inventors: Gary A. Hite, Edward D. Mihelich, Tulio Suarez
  • 3-Phenyl-4-benzoyl-1,2-dihydronaphthalenes
    Patent number: 4400543
    Abstract: Derivatives of 3-phenyl-4-aroyl-1,2-dihydronaphthalenes and 1-aroyl-2-phenylnaphthalenes are useful as antifertility agents.
    Type: Grant
    Filed: February 1, 1982
    Date of Patent: August 23, 1983
    Assignee: Eli Lilly and Company
    Inventors: Tulio Suarez, C. David Jones
  • Antifertility compounds
    Patent number: 4323707
    Abstract: Derivatives of 3-phenyl-4-aroyl-1,2-dihydronaphthalenes and 1-aroyl-2-phenylnaphthalenes are useful as antifertility agents.
    Type: Grant
    Filed: May 12, 1980
    Date of Patent: April 6, 1982
    Assignee: Eli Lilly and Company
    Inventors: Tulio Suarez, C. David Jones
  • Antifertility compounds
    Patent number: 4230862
    Abstract: Derivatives of 3-phenyl-4-aroyl-1,2-dihydronaphthalenes and 1-aroyl-2-phenylnaphthalenes are useful both as antifertility agents and in suppressing the growth of mammary tumors.
    Type: Grant
    Filed: August 3, 1978
    Date of Patent: October 28, 1980
    Assignee: Eli Lilly and Company
    Inventors: Tulio Suarez, C. David Jones
  • 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
    Patent number: 4133814
    Abstract: Derivatives of 2-phenyl-3-aroylbenzothiophenes and 2-phenyl-3-aroylbenzothiophene-1-oxides are useful as antifertility agents. Certain of these compounds also are useful in suppressing the growth of mammary tumors.
    Type: Grant
    Filed: September 17, 1976
    Date of Patent: January 9, 1979
    Assignee: Eli Lilly and Company
    Inventors: C. David Jones, Tulio Suarez
  • Novel antifertility agents
    Patent number: 4075223
    Abstract: Derivatives of 2-aroyl-3-phenylindenes, 3-aroyl-4-phenyl-1,2-dihydronaphthalenes, and 1-phenyl-2-aroyl-naphthalenes are useful as antifertility agents.
    Type: Grant
    Filed: November 24, 1976
    Date of Patent: February 21, 1978
    Assignee: Eli Lilly and Company
    Inventors: Tulio Suarez, C. David Jones
  • Antifertility compounds
    Patent number: 4075227
    Abstract: Derivatives of 2-aroyl-3-phenylbenzothiophenes and 2-aroyl-3-phenylbenzothiophene-1-oxides are useful as antifertility agents.
    Type: Grant
    Filed: November 22, 1976
    Date of Patent: February 21, 1978
    Assignee: Eli Lilly and Company
    Inventors: C. David Jones, Tulio Suarez
  • Novel antifertility agents
    Patent number: 4017546
    Abstract: Derivatives of 2-aroyl-3-phenylindenes, 3-aroyl-4-phenyl-1,2-dihydronaphthalenes, and 1-phenyl-2-aroyl-naphthalenes are useful as antifertility agents.
    Type: Grant
    Filed: October 28, 1975
    Date of Patent: April 12, 1977
    Assignee: Eli Lilly and Company
    Inventors: Tulio Suarez, C. David Jones